Frontiers | Editorial: Evaluating surgical techniques and perioperative strategies in colorectal cancer treatment
Colorectal cancer surgery has moved beyond an era in which progress was measured almost exclusively by the ability to perform a safe resection.
This editorial synthesizes recent findings on how advances in colorectal cancer surgery—ranging from robotic and fluorescence‑guided techniques to enhanced recovery and pre‑habilitation pathways—are shifting the focus from purely technical outcomes to an integrated, patient‑centred model of care.
Evidence level: Számítógépes vagy elméleti. Modellből vagy adatbányászatból származó jel.
Related signals
- Encorafenib, Binimetinib, and Cetuximab in BRAF V600E‑Mutated Colorectal Cancer
- Current and emerging therapeutic approaches for colorectal cancer: A comprehensive review
- Three Versus 6 Months of Adjuvant Oxaliplatin‑Fluoropyrimidine Chemotherapy for Colorectal Cancer: Final Results of SCOT—An International, Randomized, Phase III, Noninferiority Trial
- Duration of Adjuvant Chemotherapy for Stage III Colon Cancer
- Emerging and Established Targets in Colorectal Cancer: Translating Biology Into Therapeutics